Innovative NanoBioTec & Translational Drug Delivery

The IN-TDDR research group specializes in innovative nanobiotechnology and translational drug delivery. It develops smart, safe, and sustainable pharmaceutical systems, bridging laboratory research with clinical, industrial, and environmental applications. The group addresses global challenges such as cancer therapy, antimicrobial resistance, and sustainable materials.

  • Smart oral and targeted drug delivery systems
  • Nanogels and hydrogels for therapy
  • Green nanocomposites from natural waste for pharma & water purification

​Vortioxetine-protein complex encapsulated in bio-adhesive polymeric nano micelles (Patent No. SA 23007 B1), Saudi Authority for Intellectual Property, 2026. Retrieved from https://www.saip.gov.sa

Recent High-Impact (2025–2026):

  • Applied Science Private University Grant (2026)
  • PNURSP projects (2024–2026)
  • King Abdulaziz University grants
  • Ministry of Higher Education funding

Status: Ongoing & completed